Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
Smoldering multiple myeloma (SMM) is an asymptomatic disorder of clonal bone marrow (BM) plasma cells (PCs) in between the premalignant condition known as monoclonal gammopathy of undetermined significance and overt multiple myeloma (MM). It is characterized by a deep biological heterogeneity that i...
Main Authors: | Marta Lionetti, Matteo C. Da Vià, Francesco Albano, Antonino Neri, Niccolò Bolli, Pellegrino Musto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3319 |
Similar Items
-
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
by: Martina Manzoni, et al.
Published: (2020-05-01) -
What Is New in the Treatment of Smoldering Multiple Myeloma?
by: Niccolo’ Bolli, et al.
Published: (2021-01-01) -
How we manage smoldering multiple myeloma
by: Alessandra Romano, et al.
Published: (2020-09-01) -
Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
by: Magda Zanelli, et al.
Published: (2021-01-01) -
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
by: Efrat Markus, et al.
Published: (2020-05-01)